Table 2.

Baseline characteristics of FTLD-TDP and control cohorts

Method	Cohort	Number (N)	Male/Female (N)(%)	Age * (y)(CI)	Neuropathology (N)(%)	TDP-43 Type (1/2/3)(%)	Known Mutations (N)(%)
Sequencing	FTLD-TDP	141	76/65 (54/46)	73.1 (71.3–74.9)	141/0 (100/0)	77/23/28 (60/18/22)	54 (38%)
TaqMan	CON	1167	536/631 (46/54)	70.8 (70.2–71.5)	N/A	N/A	N/A

Abbreviations: FTLD-TDP = frontotemporal lobar degeneration with TDP-43 pathology, CON = control subjects, and N/A = not applicable.

^*Age at death is shown for FTLD-TDP patients, and age at sampling for control subjects.